Production (Stage)
Quest Diagnostics Incorporated
DGX
$171.23
$1.610.95%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.38% | 6.70% | 2.60% | -1.50% | -3.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.38% | 6.70% | 2.60% | -1.50% | -3.29% |
| Cost of Revenue | 9.40% | 6.71% | 3.20% | -0.10% | -1.74% |
| Gross Profit | 9.34% | 6.68% | 1.42% | -4.22% | -6.28% |
| SG&A Expenses | 8.57% | 7.31% | -3.83% | -11.01% | -11.61% |
| Depreciation & Amortization | 23.42% | 17.59% | -2.50% | -6.67% | -6.72% |
| Other Operating Expenses | 200.00% | 0.00% | 90.00% | 100.00% | 93.33% |
| Total Operating Expenses | 9.45% | 6.98% | 1.82% | -2.38% | -3.84% |
| Operating Income | 8.95% | 5.06% | 7.64% | 4.08% | 0.07% |
| Income Before Tax | 5.75% | 3.29% | 10.95% | 5.86% | 6.49% |
| Income Tax Expenses | 6.83% | 10.08% | 20.10% | 14.29% | 13.70% |
| Earnings from Continuing Operations | 5.45% | 1.43% | 8.67% | 3.73% | 4.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.77% | 7.41% | 12.50% | 21.88% | 19.70% |
| Net Income | 6.03% | 1.99% | 10.22% | 5.79% | 6.68% |
| EBIT | 8.95% | 5.06% | 7.64% | 4.08% | 0.07% |
| EBITDA | 10.56% | 6.84% | 6.87% | 3.62% | 0.62% |
| EPS Basic | 6.43% | 2.56% | 11.04% | 7.62% | 9.66% |
| Normalized Basic EPS | 4.47% | 2.44% | 9.05% | 7.84% | 7.23% |
| EPS Diluted | 7.63% | 3.81% | 10.73% | 6.92% | 8.63% |
| Normalized Diluted EPS | 4.49% | 2.67% | 9.75% | 8.27% | 7.39% |
| Average Basic Shares Outstanding | -0.45% | -0.67% | -0.67% | -1.55% | -2.40% |
| Average Diluted Shares Outstanding | -0.44% | -0.88% | -1.32% | -1.96% | -2.58% |
| Dividend Per Share | 5.90% | 5.63% | 6.09% | 6.57% | 7.06% |
| Payout Ratio | -0.01% | 0.03% | -0.04% | -0.01% | -0.02% |